POLLUX & amp; CASTOR Studies for Relapsed or Refractory Multiple Myeloma
Mark Wildgust, Vice President of Global Medical Affairs for Janssen Oncology gives an overview of the POLLUX/CASTOR studies, which looked at daratumumab in combination with lenalidomide plus dexametha...
Author: ASCO2017
Added: 06/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts